Posted on

cbd dosage for lung cancer

Cbd dosage for lung cancer

This is just one case report, with only one other similar case reported, caution the authors. And it’s not clear which of the CBD oil ingredients might have been helpful, the doctors said.

Early Signs of Lung Cancer. Consult Doctor If You Notice These Symptoms

“Although there appears to be a relationship between the intake of CBD oil and the observed tumour regression, we are unable to conclusively confirm that the tumour regression is due to the patient taking CBD oil,” they pointed out.

“Without the knowledge of her clinicians, she chose to self-administer ‘cannabidiol (CBD) oil’ orally 2-3 times daily,” the doctors wrote in the paper.

In the paper, doctors at the Respiratory Department, at Watford General Hospital in the UK wrote that the woman was diagnosed with non-small cell lung cancer in 2018 and her tumour was 41 mm in size.

The woman told doctors that the supplier advised that hot food or drinks should be avoided when taking the oil as she might otherwise feel stoned. The woman said she had reduced appetite since taking the oil but had no other obvious ‘side effects’. There were no other changes to her prescribed meds, diet, or lifestyle. And she continued to smoke throughout.

But as the tumour showed no evidence of local or further spread, she was suitable for conventional treatment of surgery, chemotherapy, and radiotherapy.

“Serial imaging showed that her cancer reduced in size progressively from 41 mm to 10 mm over a period of 2.5 years,” they added.

Regular CT scans every 3-6 months showed her tumour progressively shrinking in size from 41 mm in June 2018 to 10 mm by February 2021, equalling to an overall 76 per cent reduction in maximum diametre, averaging 2.4 per cent a month.

Why COVID-19 Pandemic Has Made Early Detection of Lung Cancer a Challenge

“We are unable to confirm the full ingredients of the CBD oil that the patient was taking or to provide information on which of the ingredient(s) may be contributing to the observed tumour regression,” they point out.

“More research is needed to identify the actual mechanism of action, administration pathways, safe dosages, its effects on different types of cancer and any potential adverse side effects when using cannabinoids,” they conclude.

These showed that the tumour was progressively shrinking, reducing in size from 41 mm in June 2018 to 10 mm by February 2021, equal to an overall 76% reduction in maximum diameter, averaging 2.4% a month, say the report authors.

Funding: None declared

This is just one case report, with only one other similar case reported, caution the authors. And it’s not clear which of the CBD oil ingredients might have been helpful.

The report authors describe the case of a woman in her 80s, diagnosed with non-small cell lung cancer. She also had mild chronic obstructive pulmonary disease (COPD), osteoarthritis, and high blood pressure, for which she was taking various drugs.

The supplier had advised that the main active ingredients were Δ9-­tetrahydrocannabinol (THC) at 19.5%, cannabidiol at around 20%, and tetrahydrocannabinolic acid (THCA) at around 24%.

Chemically similar to these endocannabinoids, cannabinoids can interact with signalling pathways in cells, including cancer cells. They have been studied for use as a primary cancer treatment, but the results have been inconsistent.